Ameriprise
GNBT

Ameriprise’s GENEREX BIOTECHNOLOGY CORP GNBT Stock Holding History

Ameriprise’s Portfolio GNBT Stock Details GNBT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2016
Q3 		– Sell
-34,050
Closed – – 3943
2016
Q2 		$0 Buy
+34,050
New – ﹤0.01% 3937

Ameriprise's GNBT Position: Q3 2016 in Review

Ameriprise sold out of GENEREX BIOTECHNOLOGY CORP (GNBT) in Q3 2016, closing a stake of 34,050 shares.

Ameriprise first reported a position in GNBT in Q2 2016 and held it in 1 quarter. The position peaked at $0 in Q2 2016. 0 funds tracked by Wall St. Rank hold GNBT as of Q3 2016.

  • Ameriprise reported no remaining GENEREX BIOTECHNOLOGY CORP position as of Q3 2016 after selling out during the quarter.
  • Ameriprise sold 34,050 GENEREX BIOTECHNOLOGY CORP shares in Q3 2016.
  • Ameriprise first reported a position in GENEREX BIOTECHNOLOGY CORP in Q2 2016 and held it in 1 quarter.
  • Ameriprise's GENEREX BIOTECHNOLOGY CORP position peaked at $0 in Q2 2016.
  • 0 funds tracked by Wall St. Rank held GENEREX BIOTECHNOLOGY CORP as of Q3 2016.

Based on Ameriprise's 13F filing for Q3 2016, filed 8 Nov 2016.